How is the Ionis Pharmaceuticals Inc today?

The Ionis Pharmaceuticals Inc today is trading in the green, up by 1.19% at 33.91.

How has Ionis Pharmaceuticals Inc performed historically?

The Ionis Pharmaceuticals Inc is currently trading up 1.19% on an intraday basis in the past week the index rose 2.82%. The index has been up 2.17% in the past quarter and fell -9.74% in the past year. You can view this in the overview section.

What is Ionis Pharmaceuticals Inc Annual Revenue?

Ionis Pharmaceuticals Inc Annual Revenue fell 10.48%, in the last year to $705.14 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Ionis Pharmaceuticals Inc Annual Net Profit?

Ionis Pharmaceuticals Inc Annual Net Profit fell 23.92% in the last year to $453.9 M. Its sector's average net profit growth for the last fiscal year was -11.09%.

What is Ionis Pharmaceuticals Inc Price to Earning Ratio?

Ionis Pharmaceuticals Inc Price to Earning Ratio is -11.78, which is negative.

What is Ionis Pharmaceuticals Inc Stock Price?

Ionis Pharmaceuticals Inc Stock Price fell 9.74% and underperformed its sector by 49.36% in the past year.

What is Ionis Pharmaceuticals Inc Quarterly Revenue?

Ionis Pharmaceuticals Inc Quarterly Revenue rose 10.14% YoY to $131.61 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Ionis Pharmaceuticals Inc Quarterly Net profit?

Ionis Pharmaceuticals Inc Quarterly Net profit fell 2.9% YoY to $146.94 M. Its sector's average net profit growth YoY for the quarter was -212.88%.

What is Ionis Pharmaceuticals Inc Debt to Equity Ratio?

Ionis Pharmaceuticals Inc Debt to Equity Ratio of 2.41 is higher than 1. This implies that company assets are financed through debt.

What is Ionis Pharmaceuticals Inc Return on Equity(ROE)?

Ionis Pharmaceuticals Inc Return on Equity(ROE) for the last financial year was -93.1%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Ionis Pharmaceuticals Inc Mutual Fund Holding?

Ionis Pharmaceuticals Inc Mutual Fund Holding increased by 0.68% in the last quarter to 94.24.

What is Ionis Pharmaceuticals Inc Promoter Share Holding?

Ionis Pharmaceuticals Inc Promoter Share Holding increased by 0.02% in the most recent quarter to 0.86%.

What is Ionis Pharmaceuticals Inc Interest Coverage Ratio?

Ionis Pharmaceuticals Inc Interest Coverage Ratio is -4.45, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Ionis Pharmaceuticals Inc Institutional Holding?

Ionis Pharmaceuticals Inc Institutional Holding increased by 4.06% in the last quarter to 105.77.

Ionis Pharmaceuticals Inc XNAS: IONS

Ionis Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: Ionis Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Ionis Pharmaceuticals Inc
Rating: 1.2138055
Author: Trendlyne DVM scores

Momentum Trap

about

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, a...

33.91 0.40 (1.19%)

35.21% Fall from 52W High

495.8K XNAS Volume

XNAS 02 Jun, 2025 1:41 PM (EDT)

Board Meeting

The next board meeting for Ionis Pharmaceuticals Inc is on 06 Jun 2025 for the purpose of Ionis Pharmaceuticals Inc Annual General Meeting for 2025 See details

Low Financial Strength

22.2 / 100

Expensive Valuation

8.5 / 100

Technically Neutral

44.2 / 100

Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 70%

26 analysts

Ionis Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Ionis Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, a...

35.21% Fall from 52W High

SWOT Analysis

Ionis Pharmaceuticals Inc Live Price Chart

Ionis Pharmaceuticals Inc FAQ

How is Ionis Pharmaceuticals Inc today?

Ionis Pharmaceuticals Inc today is trading in the green, and is up by 1.19% at 33.91.

How has Ionis Pharmaceuticals Inc performed historically?

Ionis Pharmaceuticals Inc is currently trading up 1.19% on an intraday basis. In the past week the stock rose 2.82%. stock has been up 2.17% in the past quarter and fell -9.74% in the past year. You can view this in the overview section.